...joined existing investors Ritchie; Intersouth Partners; Lilly Ventures; Mediphase Venture Partners; Takeda Research Investment; and Seaflower Ventures...

...15.2%); Skyline Ventures (13.2%); VenGrowth (11.8%); OrbiMed (11.1%); T2 C2 (7.3%); Canadian Medical Discoveries (7.1%); Seaflower Ventures...

...series C round led by Brookside Capital; Skyline Ventures; Radius; and OrbiMed Advisors. Existing investors Seaflower Ventures...

...by Ritchie. Existing investors Intersouth Partners; Lilly Ventures; Mediphase Venture Partners; Takeda Research Investment; and Seaflower Ventures...

...Healthcare Ventures; SR One; Ontario Teacher's Pension Plan; VenGrowth Private Equity Partners; Genesys Capital Partners; Seaflower Ventures...

...Prospect Venture Partners; Frazier Healthcare Ventures; SR One; Ontario Teacher's Pension Plan; VenGrowth; Genesys Capital; Seaflower Ventures...

...Partners; Frazier Healthcare Ventures; SR One; and Ontario Teacher's Pension Plan joined VenGrowth; Genesys Capital; Seaflower Ventures...

...Ventures; The Sprout Group; ProQuest Investments; Canaan Partners; HealthCap; NewSpring Ventures; Commerce Health Ventures; and Seaflower Ventures...

...included the Sprout Group; ProQuest ; Canaan Partners; HealthCap; NewSpring Ventures; Commerce Health Ventures; and Seaflower Ventures...

...allergy and osteoporosis. Other investors included HealthCap; ProQuest Investments, Johnson & Johnson Development Corp.; Intersouth; Seaflower Ventures...